tiprankstipranks
TipRanksTop Financial ExpertsInsidersKevin Buchi

Kevin Buchi Insider Profile

4 Followers
Kevin Buchi, Director at Amneal Pharmaceuticals, holds 168.58K shares in Amneal Pharmaceuticals (Ticker: AMRX), holds 4.67K shares in Dicerna Pharma (Ticker: DRNA), holds ― shares in Biospecifics Technologies (Ticker: BSTC).
See the Hottest Stocks Based on Insider Trading >
tipranks
Kevin Buchi

Kevin Buchi
Amneal Pharmaceuticals (AMRX)
Director

Ranked #106,178 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 10 Profitable Transactions

Average Return

-84.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$4M
80.90%
18.18%
0.74%
0.19%
0.00% Others
A breakdown of Kevin Buchi's holdings
See the Top Stocks by Insiders

Insider Roles

Amneal Pharmaceuticals
(AMRX)
Director
Benitec Biopharma
(BNTC)
Director
Ampio Pharmaceuticals
(AMPE)
Director
Alaunos Therapeutics
(TCRT)
Director
+1 other positions
Roles that Kevin Buchi holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Tetralogic Pharma
(TLOG)
Rating:Informative Buy
Date:Nov 12, 2014 - Nov 12, 2015
Return:-58.10%
The most profitable trade made by Kevin Buchi
See the Latest Stocks Traded by Insiders

Kevin Buchi's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AMRX
Amneal Pharmaceuticals
Aug 13, 2026
Director
Uninformative Sell
2.90M
$2.94M
DRNA
Dicerna Pharma
―
―
―
$178.33K
BSTC
Biospecifics Technologies
―
―
―
―
TCRT
Alaunos Therapeutics
May 06, 2021
Director
Uninformative Buy
―
$6.79K
AMPE
Ampio Pharmaceuticals
Jun 13, 2023
Director
Informative Buy
6.12K
$26.88K
BNTC
Benitec Biopharma
Jun 30, 2026
Director
Uninformative Sell
―
$660.59K
TLOG
Tetralogic Pharma
Mar 30, 2015
President & CEO, Director
Informative Buy
21.10K
―
STML
Stemline Therapeutics
Jun 25, 2015
―
Uninformative Buy
―
$281.22K
ALXA
Alexza Pharmaceuticals
―
―
―
$0.00
EPRSQ
Epirus Biopharma
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Kevin Buchi's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Kevin Buchi insider profile FAQ

What is the percentage of profitable transactions made by Kevin Buchi?
The percentage of profitable transactions made by Kevin Buchi is 0%.
    What is the average return per transaction made by Kevin Buchi?
    The average return per transaction made by Kevin Buchi is -84.40%.
      What stocks does Kevin Buchi hold?
      Kevin Buchi holds: AMRX, DRNA, BSTC, TCRT, AMPE, BNTC, TLOG, STML, ALXA, EPRSQ stocks.
        What was Kevin Buchi’s latest transaction?
        Kevin Buchi latest transaction was an Uninformative Sell of $2.90M.
          What was Kevin Buchi's most profitable transaction?
          Kevin Buchi’s most profitable transaction was an Informative Buy of TLOG stock on November 12, 2014. The return on the trade was -58.10%.
            What is Kevin Buchi's role in Amneal Pharmaceuticals?
            Kevin Buchi's role in Amneal Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.